throbber
Pharmaceutical Research, Vol. 6, No. 11, 1989
`
`Review
`Stability of Protein Pharmc;1ceuticals
`
`Mark C. Manning, 1•2 Kamlesh Patel, 1 and Ronald T. Borchardt1
`
`Recombinant DNA technology has now made it possible to produce proteins for pharmaceutical
`applications. Consequently, proteins produced via biotechnology now comprise a significant portion
`of the drugs currently under development. Isolation, purification, formulation, and delivery of proteins
`represent significant challenges to pharmaceutical scientists, as proteins possess unique chemical and
`physical properties. These properties pose difficult stability problems. A summary of both chemical
`and physical decomposition pathways for proteins is given. Chemical instability can include proteo(cid:173)
`lysis, deamidation, oxidation, racemization, and !3-elimination. Physical instability refers to processes
`such as aggregation, precipitation, denaturation, and adsorption to surfaces. Current methodology to
`stabilize proteins is presented, including additives, excipients, chemical modification, and the use of
`site-directed mutagenesis to produce a more stable protein species.
`KEY WORDS: protein stability; biotechnology; mutagenesis; denaturation.
`
`INTRODUCTION
`
`With the recent advances in recombinant DNA technol(cid:173)
`ogy, the commercial production of proteins for pharmaceu(cid:173)
`tical purposes has become feasible (1,2). As a result, the
`preparation of proteins as medicinal agents has become an
`integral part of the pharmaceutical industry. Currently, there
`are more than 150 recombinant proteins in Phase I clinical
`trials or beyond, and almost a dozen have received FDA
`approval. Unfortunately, proteins possess chemical and
`physical properties which present unique difficulties in the
`purification, separation, storage, and delivery of these ma(cid:173)
`terials. Therefore, formulation of proteins differ greatly from
`that of rigid small organic molecules. Future pharmaceutical
`scientists will need to be properly trained to address the
`various aspects of protein instability. An introduction to
`these concepts is presented below, with the view that under(cid:173)
`standing protein stability at a molecular level is essential to
`solving many of their formulation problems.
`Degradation pathways for proteins can be separated
`into two distinct classes, involving chemical instability and
`physical instability. First, chemical instability can be defined
`as any process which involves modification of the protein via
`bond formation or cleavage, yielding a new chemical entity.
`Second, physical instability does not involve covalent mod(cid:173)
`ification of the protein. Rather, it refers to changes in the
`higher order structure (secondary and above). These include
`denaturation, adsorption to surfaces, aggregation, and pre-
`
`1 Department of Pharmaceutical Chemistry, The University of Kan(cid:173)
`sas, Lawrence, Kansas 66045.
`2 To whom correspondence should be addressed.
`3 Unless otherwise noted, all amino acids listed are L-enantiomers of
`the 20 common amino acids and are referred to by their three-letter
`abbreviations.
`
`cipitation. A summary of the current understanding of each
`of these processes is presented and illustrated by well(cid:173)
`characterized systems. Finally, approaches for retarding or
`inhibiting these processes and, thereby, increasing protein
`stability is presented.
`
`CHEMICAL INSTABILITY
`
`A variety of chemical reactions is known to affect pro(cid:173)
`teins (Fig. 1). These reactions can involve hydrolysis, in(cid:173)
`cluding both cleavage of peptide bonds as well as deamida(cid:173)
`tion of Asn and Gln side chains. 3 Hydrolysis at Asp-X sites
`is particularly accelerated. Oxidation of Cys can lead to di(cid:173)
`sulfide bond formation and exchange, whereas oxidation of
`Met and other amino acids may inactivate or alter the activ(cid:173)
`ity of a protein. Other decomposition reactions include beta(cid:173)
`elimination and racemization.
`
`Deamidation
`
`In the deamidation reaction, the side chain amide link(cid:173)
`age in a Gln or Asn residue is hydrolyzed to form a free
`carboxylic acid. Over the past two decades many investiga(cid:173)
`tors have observed altered forms of proteins which have
`been attributed to deamidation. Such a list contains
`lysozyme (3), bovine growth hormone (bGH) (growth hor(cid:173)
`mone is also known as somatotropin) (4), human growth
`hormone (hGH) (5,6), insulin (7,8), a-crystallin (9), cy(cid:173)
`tochrome c (10), -y-immunoglobulin (11), epidermal growth
`factor (EGF) (12), hemoglobin (13), triosephosphate isomer(cid:173)
`ase (TIM) (14,15), neocarzinostatin (16), prolactin (17), gas(cid:173)
`trin releasing peptide (18), and adrenocorticotropic hormone
`(ACTH) (19,20), suggesting that· in vitro deamidation is a
`common phenomenon.
`The hydrolysis of Asn and Gln residues for many pro(cid:173)
`teins and peptides has been observed under a variety of
`
`903
`
`0724-8741/89/1100-0903$06.00/0 © 1989 Plenum Publishing Corporation
`
`Novo Nordisk A/S Ex. 2005, P. 1
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`904
`
`Manning, Patel, and Borchardt
`
`PROTEIN PHARMACEUTICALS
`
`I\
`
`CHEMICAL INSTABILITY
`
`PHYSICAL INSTABILITY
`
`-Deamidation
`-Racemization
`-Hydrolysis
`-Oxidation
`-Beta Elimination
`-Disulfide Exchange
`
`-Denaturation
`-Aggregation
`-Precipitation
`-Adsorption
`
`Fig. 1. Summary of the chemical and physical instability processes
`observed in protein pharmaceuticals.
`
`chemical conditions and has been reviewed by Robinson and
`Rudd (21). Interestingly, it was realized that the deamidation
`of Asn residues, which occurs most often at the sequence
`Asn-Gly, was accelerated at neutral or alkaline conditions
`(22-24). The rates were also higher relative to the hydrolysis
`of the amino acid Asn itself (21). An explanation is that
`deamidation is believed to proceed through a five-membered
`cyclic imide intermediate formed by intramolecular attack of
`the succeeding peptide nitrogen at the side chain carbonyl
`carbon of the Asn residue (see Fig. 2) (25). Subsequently, the
`cyclic imide spontaneously hydrolyzes to give a mixture of
`peptides in which the polypeptide backbone is attached via
`an o:-carboxyl linkage (Asp) or is attached via a 13-carboxyl
`linkage (iso-Asp) (23). Similarly, Gln can also undergo de(cid:173)
`amidation via formation of a six membered ring (23). Most of
`the information on the mechanism and rate of deamidation of
`
`0 • rNH,
`R
`CH2
`I
`I
`-NH-CH-WNH-CH- ~-
`0
`0
`
`L- Asparaginyl peptide
`
`0
`
`I
`-NH-CII-C.....
`II
`
`II
`0
`
`N1 slow
`D-isoAspartyl peptide
`CH,k r
`11
`N- OI-C- -== D - Cyclic imide
`If
`+"f)'j/ L- Cycl~ imid~~zO
`~,o
`+H,~
`
`D-Aspartyl peptide
`
`0
`I c-o·
`
`I r
`
`-NH-CH-C-NH-CH- c-
`u
`u
`0
`0
`
`r
`
`R
`0
`I
`n
`CH-C-NK-CH-C-
`J 2
`II
`0
`-NH-CH-c-o·
`'
`0
`
`L-Aspartyl peptide
`Fig. 2. Pathways for spontaneous deamidation, isomerization, and
`racemization for aspartyl and asparaginyl peptides.
`
`L-isoAspartyl peptide
`
`Asn residues has been obtained from studies on short model
`peptides (26,27). Clear evidence for a deamidation mecha(cid:173)
`nism involving the cyclic imide intermediate has been ob(cid:173)
`tained by Geiger and Clarke (26). In their study, deamidation
`of a hexapeptide sequence based on residues 22-27 of ACTH
`(Val-Tyr-Pro-Asn-Gly-Ala) was studied at 37°C and pH 7.4.
`Evidence from these studies supporting cyclic imide forma(cid:173)
`tion include the appearance of iso-Asp, Asp, and cyclic im(cid:173)
`ide peptides upon deamidation and a ratio of the iso-Asp to
`Asp peptide formed in the deamidation of this hexapeptide
`(2.8: 1) is the same as that found when purified cyclic imide is
`hydrolyzed (3 .1: 1). If there is a significant amount of direct
`solvent hydrolysis of the amide linkage occurring, the pro(cid:173)
`portion of Asp peptide relative to iso-Asp peptide in the
`deamidation of a hexapeptide would have increased, which
`is not the case. The presence of iso-Asp products from the
`incubations of proteins and peptides implies cyclic imide for(cid:173)
`mation as an intermediate in deamidation reaction (28-32).
`The Fourier transform infrared photoacoustic spectroscopic
`measurements (FTIR-PAS) have also provided direct evi(cid:173)
`dence for the formation of a cyclic imide in peptides with
`Asn-Gly sequences induced by heating in the dry state (33).
`Recently, we have shown that both Asp- and iso(cid:173)
`Asp-hexapeptides are formed upon deamidation of Val(cid:173)
`Tyr-Pro-Asn-Gly-Ala, ACTH22- 27 (Asn-hexapeptide), in the
`pH range of 5 to 12 at 37°C (34,35). This further confirms the
`formation of a cyclic imide intermediate in the deamidation
`process at neutral and alkaline pH's. In the pH range 7 to 12,
`buffer concentration had significant effect on the rate of de(cid:173)
`amidation, indicating general acid-base catalysis. No buffer
`catalysis was observed at pH 5, 6, and 6.5. The ratio of
`iso-Asp- and Asp-hexapeptides was independent of buffer
`concentration at all pH's and was approximately 4:1. At
`acidic pH's (pH 1-2), the deamidation was much slower than
`at alkaline pH, and only Asp-hexapeptide was produced
`upon deamidation. Although iso-Asp-hexapeptide was not
`detected at acidic pH, one new product (Val-Tyr-Pro-Asp)
`was observed by HPLC. These results suggest that at acidic
`pH, the probable mechanism of deamidation is direct hydrol(cid:173)
`ysis of the amide side chain of Asn, to form the Asp(cid:173)
`hexapeptide, which further degrades in acidic media via pep(cid:173)
`tide bond cleavage at the Asp-Gly bond. Reactions at pH 3
`and 4 were very slow at 37°C (degradation of Asn(cid:173)
`hexapeptide was not detected for 60 days).
`By comparison, when deamidation experiments were
`carried out with ACTH (1-39), the separation of Asp- and
`iso-Asp products could not be achieved by either isoelectric
`focusing or cation-exchange HPLC (20). However, these
`techniques did separate native ACTH from the deamidated
`ACTHs (Asp- and iso-Asp-ACTH). The rate constants for
`the deamidation of both ACTH and Asn-hexapeptide
`(ACTH22-27) at pH 2.0, 7.0, and 9.6 at 37°C were similar.
`Formation of the iso-Asp product upon deamidation of
`ACTH at pH 7.0 and 9.6 was verified by the protein car(cid:173)
`boxymethyltransferase (PCM)-catalyzed methylation of de(cid:173)
`amidated ACTH. No such methylation was observed when
`ACTH was incubated at pH 2.0, 37°C. These data indicate
`the in~olvement of cyclic imide intermediate at neutral and
`alkaline pH but not at pH 2.0.
`Since the formation of a cyclic imide involves partici(cid:173)
`pation of the succeeding amino acid, the size and physico-
`
`Novo Nordisk A/S Ex. 2005, P. 2
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`Stability of Protein Pharmaceuticals
`
`905
`
`chemical properties of neighboring amino acid side chain is
`expected to play an important role in the rate of formation of
`cyclic imide. Evidence in support of this conclusion comes
`from studying the rates of cyclic imide formation in peptides
`containing Asn (26) or Asp ~-benzyl esters (36-45). For ex(cid:173)
`ample, the rate of cyclic imide formation at pH 7.4 was ap(cid:173)
`proximately 50 times slower in the Asn-Leu-hexapeptide
`than the Asn-Gly-hexapeptide due to steric hinderance by
`the Leu side chain (26).
`Robinson and co-workers (46-49) investigated the non(cid:173)
`enzymatic deamidation of Asn residues in synthetic pen(cid:173)
`tapeptides, and the effects ofamino acid sequence, pH, tem(cid:173)
`perature, buffer species, and ionic strength. Using synthetic
`pentapeptides, it has been shown that deamidation is favored
`by increased pH, temperature, and ionic strength (46,47).
`These studies showed the importance of primary sequence
`around the Asn residue, but did not investigate the formation
`of either iso-Asp or cyclic imide. Similar results are obtained
`for cytochrome c (50). Similarly, the rate of deamidation of
`human TIM was facilitated by high temperatures, and was
`also found to be dependent on the presence of substrate and
`specific buffers (14). Unlike the hydrolysis of peptides con(cid:173)
`taining esters of Asp, where the cyclic imide intermediate
`can be trapped (22,24), cyclic imide formation during the
`deamidation of Asn peptides is the rate determining step
`(26,27).
`The rates of deamidation of Asn residues in proteins are
`influenced by the secondary and tertiary structures of pro(cid:173)
`teins. Clarke has shown that Asp and Asn residues in native
`proteins generally exist in conformations where the peptide
`bond nitrogen atom cannot approach the side chain carbonyl
`carbon without large scale conformational changes (51).
`Therefore, certain proteins will not undergo deamidation un(cid:173)
`less they have been denatured. Cyclic imide could only be
`formed in vitro at Asn67 of bovine pancreatic ribonuclease in
`the unfolded state (52). While in the native structure, this
`residue is poorly positioned for cyclic imide formation. Sim(cid:173)
`ilarly, it has been shown that urea (a strong denaturant)
`accelerates the deamidation of bGH, hGH, and prolactin,
`presumably by unfolding the protein (5). Tertiary structure
`appears to be the principle determinant for the de(cid:173)
`amidation of trypsin (53). The study also showed that adja(cid:173)
`cent Ser residues aid in the formation of the cyclic imide
`intermediate, consistent with earlier studies on small peptide
`systems (36,37). Recently, Lura and Schirch (54) have
`shown that the mechanism of deamidation of Val-Asn(cid:173)
`Gly-Ala and N-acetyl-Val-Asn-Gly-Ala varies according to
`the conformation of the peptide backbone. Above pH 9.0,
`both peptides have similar conformations and thus deami(cid:173)
`date by the same mechanism to give mixture of Asp and
`iso-Asp peptides. However, at pH 7.0, while the N-acetyl
`peptide yielded a mixture of Asp and iso-Asp peptides, the
`non-acetylated peptide gave no detectable amounts of these
`products, but rather yielded a cyclic peptide believed to be
`formed by nucleophilic attack of the amide of the Asn resi(cid:173)
`due by the terminal amino group.
`It is well known that peptides of Asp esters undergo
`intramolecular cyclization, under both acidic and basic con(cid:173)
`ditions, leading to a cyclic imide derivative (39,55). How(cid:173)
`ever, no reports are available showing the formation of cy(cid:173)
`clic imide from Asn peptides in acidic media. There are few
`
`examples in the literature which at least indicate that cyclic
`imide is not involved in the deamidation reaction under
`acidic conditions. For example, insulin (7,8), neocarzinosta(cid:173)
`tin (16), and ribonuclease A (56), when incubated in acidic
`media, yield only Asp-containing products from the deami(cid:173)
`dation of Asn residues. Similar results were obtained by
`Meinwald and co-workers (27), where Ac-Asn-Gly-NHMe
`produced only Ac-Asp-Gly-NHMe and the analogous iso(cid:173)
`Asn produced only the iso-Asp-containing peptide after 1
`day in 1 M HCl.
`It has been postulated that deamidation may play a cen(cid:173)
`tral role as a timer in protein turnover and in aging (21).
`However, for pharmaceutical preparations, the major con(cid:173)
`cern is the change in protein function upon deamidation. In
`a few cases, the deamidation of specific Asn residues has
`been linked to the changes in the protein function, for ex(cid:173)
`ample, deamidation at two Asn-Gly sequences in TIM re(cid:173)
`sulted in subunit dissociation (15). Deamidation at an Asn(cid:173)
`Gly site in a hemoglobin mutant (Hb providence) changed its
`oxygen affinity (57), and deamidation at an Asn-Asp site in
`hGH altered its proteolytic cleavage properties (58). Re(cid:173)
`cently, deamidation was shown as one of the major chemical
`processes responsible for irreversible enzyme inactivation of
`lysozyme (59) and ribonuclease (60) at 100°C. Deamidation
`was also responsible for the decrease in biological activity
`for porcine ACTH (62) and slower rate of refolding after
`deamidation for ribonuclease (63,64).
`With small peptides, the iso-Asp and Asp peptides are
`separable by chromatographic or electrophoretic methods
`(65-67). However, with larger proteins similar methodology
`has not been successful. Chromatofocusing (68) and HPLC
`(20,29) have been used for separating the native protein from
`the product mixture, but these techniques do not separate
`the iso-Asp-peptide from the Asp-peptide. However, there
`are several indirect ways of showing the presence ofiso-Asp
`residues in proteins. These include (i) NMR methods to dis(cid:173)
`tinguish Asp and iso-Asp (27,54,69); (ii) Leu aminopeptidase
`digestion, since this enzyme will not cleave an iso-Asp pep(cid:173)
`tide bond (67,70); (iii) tryptic peptide mapping and amino
`acid sequencing (71); and (iv) use of PCM, which is known to
`methylate selectively the free a-carboxy group of iso-Asp
`peptides (72). Recently, Johnson and co-workers have
`shown the use of this enzyme as a powerful analytical tool
`for estimating minimum levels of protein deamidation (73).
`In their work, they monitored the increase in methylation for
`aldolase, bovine serum albumin, cytochrome c, lysozyme,
`ovalbumin, ribonuclease A, and TIM upon incubation at pH
`11, finding evidence that iso-Asp is formed upon deamida(cid:173)
`tion.
`
`Oxidation
`
`The side chains of His, Met, Cys, Trp, and Tyr residues
`in proteins are potential oxidation sites. Even atmospheric
`oxygen can oxidize Met residues. Oxidation has been ob(cid:173)
`served in many peptide hormones during their isolation (74-
`77), synthesis (78), and storage (79). Since the thioether
`group of Met is a weak nucleophile and is not protonated at
`low pH, it can be selectively oxidized by certain reagents
`under acidic conditions (80). For example, hydrogen perox(cid:173)
`ide can modify indole, sulfuydryl, disulfide, imidazole, phe-
`
`Novo Nordisk A/S Ex. 2005, P. 3
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`906
`
`Manning, Patel, and Borchardt
`
`nol and thioether groups of proteins at neutral or slightly
`alkaline conditions, but under acidic conditions the primary
`reaction is the oxidation of Met to Met sulfoxide (81). In
`addition to hydrogen peroxide, a variety of other reagents
`have been used to oxidize Met to Met sulfoxide. These in(cid:173)
`clude periodate, iodine, dimethylsulfoxide, a dye-sensitized
`photooxidation, chloramine-T, and N-chlorosuccinamide
`(82,83). To oxidize Met to Met sulfone, more drastic condi(cid:173)
`tions and reagents are needed, e.g., 95% performic acid. The
`structures of the oxidation products of Met, i.e. Met sulfox(cid:173)
`ide and Met sulfone, are shown in Fig. 3.
`Oxidation of Met residues to their corresponding sulfox(cid:173)
`ides is associated with loss of biological activity for many
`peptide hormones [e.g., corticotropin (84), o:- and
`13-melanotropins (85), parathyroid hormone (86), gastrin
`(87), calcitonin (88), and corticotropin releasing factor (77)]
`as well as nonhormonal peptides and proteins (81). It has
`been shown that E. coli ribosomal protein Ll2 loses activity
`after oxidation of Met residues to Met sulfoxide and that the
`activity can be restored by incubating the protein with high
`concentrations of j3-mercaptoethanol (89). Restoration of bi(cid:173)
`ological activity was found to coincide with the reduction of
`Met sulfoxide to Met (89). Alpha-1-proteinase inhibitor pro(cid:173)
`tein, which is a major serum inhibitor of elastase activity,
`loses its ability to inactivate elastase when chemically oxi(cid:173)
`dized (90,91). Oxidation by hydrogen peroxide of a single
`Met residue in subtilisin at pH 8.8 occurs concurrently with
`changes in kinetic parameters of the enzyme, although it
`does not abolish enzymatic activity (92). Similar results were
`obtained with a disulfoxide derivative of o:-chymotrypsin
`(93,94), and trypsin (95). In many cases, such as parathyroid
`hormone (86), ribonuclease S-peptide (96), ribonuclease
`
`(97), and lysozyme (98), reduction of Met sulfoxide by thiols
`results in the recovery of nearly full biological activity.
`There are also examples where protein functions are not
`affected upon Met oxidation. Active monosulfoxide deriva(cid:173)
`tives of pancreatic ribonuclease (99), o:-chymotrypsin (100),
`and Kunitz trypsin inhibitor (101) have been prepared using
`mild hydrogen peroxide treatment at low pH (pH 1 to 3).
`Similarly, EGF (102,103) and glucagon (104) are biologically
`active when chemically oxidized.
`It is also shown that within a given protein, the reactiv(cid:173)
`ity of Met residues towards oxidation may be different de(cid:173)
`pending upon their position. For example, in hGH, Met170
`was found to be completely resistant to oxidation by hydro(cid:173)
`gen peroxide (105). In addition, it was shown that when bio(cid:173)
`synthetic hGH is chemically oxidized at Met 14, it exhibits
`full biological activity and has immunoreactivity identical to
`that of authentic hGH (6). In human chorionic somatomam(cid:173)
`motropin (hCS), Met64, Met16, and Met179 have markedly
`different reaction rates (105). The oxidation of Met64 and/or
`Met179 markedly reduced both its affinity for lactogenic re(cid:173)
`ceptors and its in vitro biological potency (105).
`Determination of oxidized Met in proteins is generally a
`problem, because during conventional amino acid analysis
`Met sulfoxide is converted to Met during acid hydrolysis.
`Therefore, Met is commonly determined by using its specific
`reactions with alkyl halides (106) or cyanogen bromide (107),
`to which the sulfoxide is resistant. After alkylating the Met
`residues of the peptide, its Met sulfoxide is oxidized with
`performic acid to the acid stable sulfones; the sulfone con(cid:173)
`tent, determined by amino acid analysis, is then used to
`correct the Met estimate obtained by conventional amino
`acid analysis (99). Alternatively, Met containing peptides
`have been separated from peptides containing oxidized Met
`residues by ion-exchange chromatography (108), counter(cid:173)
`current distribution (109), HPLC (103,110), or affinity chro(cid:173)
`matography (111). A radioassay for non oxidized Met in pep(cid:173)
`tide hormones based on its specific reaction with
`iodo[2- 14C]acetic acid is also developed (112).
`The thiol group of Cys (RSH) can be oxidized in steps,
`successively, to a sulfenic acid (RSOH), a disulfide (RSSH),
`a sulfinic acid (RSO2H), and, finally, a sulfonic acid
`(RSO3H), depending upon reaction conditions. The factors
`which influence the rate of oxidation include the tempera(cid:173)
`ture, pH, and buffer medium used, the type of catalyst (e.g.,
`traces of metal ions), and the oxygen tension (113). An im(cid:173)
`portant factor is the spatial positioning of the thiol groups in
`the proteins. In those cases where contact between thiol
`groups within the molecule of the protein is hindered, or
`when the protein contains only a single thiol group, intramo(cid:173)
`lecular disulfide bonds are not formed, but sometimes, under
`favorable steric conditions, intermolecular disulfide bonds
`arise, and the protein aggregates (114). Thiol groups are ox(cid:173)
`idized not only when oxidizing agents (e.g., iodine, ferricy(cid:173)
`anide, tetrathionate, O-iodosobenzoate, and hydrogen per(cid:173)
`oxide) are added, but also "spontaneously," by oxygen from
`the air (autooxidation). The oxidation ofthiol groups by mo(cid:173)
`lecular oxygen takes place at an appreciable rate in the pres(cid:173)
`ence of catalytic quantities of metal ions, such as iron and
`copper ions (115,116). The speed ofoxidation of thiol groups
`is also greatly influenced by the nature of neighboring
`
`CH3
`I
`s
`I
`r2
`
`,~
`
`R-C-N-1-CH - R' a.,_) ~Hz .... 0 .... ,___ R-C-N-1-CH -
`I
`I
`0
`0
`Sulfoxide
`
`CH,
`I
`s-o
`I
`
`,~
`r
`
`R'
`
`CH3 I
`o-s-o
`I
`c~
`I
`c~
`I
`R- C-N-1-CH -
`I
`0
`
`R'
`
`Sulfone
`Fig. 3. Mechanism of oxidation of Met-containing peptide under (a)
`mild and (b) strong conditions.
`
`Novo Nordisk A/S Ex. 2005, P. 4
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`Stability of Protein Pharmaceuticals
`
`907
`
`groups. This was clearly demonstrated by Barron et al. (117)
`and also by Ovaberger and Ferraro (118). From their findings
`it appears that the rate of oxidation of dithiols is diminished
`on increasing the distance between the thiol groups in the
`molecule and also under the influence of neighboring elec(cid:173)
`tronegative groups such as carboxyl group (i.e., groups that
`raise the pKa of the thiol group). This fact indicates that the
`mercaptide ion is oxidized more easily than the undissoci(cid:173)
`ated thiol group. Thus, it is shown that usually the oxidation
`rate increases with increasing pH (119). At 90°C and pH 8.0,
`a-amylase from Bacillus was shown to undergo irreversible
`thermoinactivation due to air oxidation of the Cys residues
`along with formation of incorrect or "misfolded" structures
`(120). Inactivation of rabbit muscle glyceraldehyde-
`3-phosphate dehydrogenase by hydrogen peroxide has been
`shown to result from sulfuydryl group modification to
`sulfenic acid (114). Various methods for quantitative deter(cid:173)
`mination of thiol and disulfide groups in proteins are de(cid:173)
`scribed by Torchinskii (121).
`The side chains of His, Tyr, Met, Cys, and Trp residues
`can also be oxidized by visible light in the presence of dyes,
`i.e., via photooxidation. The specificity for the various
`amino acid side chains is particularly determined by pH.
`Oxidation of His is a rapid reaction at neutral pH but is quite
`slow at low pH. At higher pH, Tyr is most reactive (122-
`124), while Trp and Met are the only amino acids readily
`oxidized below pH 4. More information on photooxidation is
`available in a few review articles (125-127). In many cases,
`loss of enzymatic activity following photooxidation has been
`attributed to the destruction of critical His residues. For
`example, the inactivation ofrabbit muscle aldolase (128), pig
`heart aspartate aminotransferase (129,130), cytochrome c
`(131), renin, and yeast enolase (132) has been attributed to
`photodegradation of His residues.
`
`Proteolysis
`
`It has been established that peptide bonds of Asp resi(cid:173)
`dues are cleaved in dilute acid at a rate at least 100 times
`faster than other peptide bonds (133). Selective hydrolysis is
`usually achieved by heating for 5-18 hr at 110°C in either
`0.03 N HCl or 0.25 N acetic acid (134). The mechanism of
`hydrolysis undoubtedly involves intramolecular catalysis by
`a carboxyl group of the Asp residue. Hydrolysis can take
`place at either the N-terminal and/or C-terminal peptide
`bonds adjacent to the Asp residue. Inglis (135) has described
`the mechanism for such hydrolysis as shown in Fig. 4, where
`cleavage of the N-terminal peptide bond would proceed via
`an intermediate containing a six membered ring rather than
`via a five-membered ring as proposed for C-terminal peptide
`fission. Such peptide bond cleavage can contribute to the
`inactivation of proteins. Significant irreversible thermoinac(cid:173)
`tivation in lysozyme (59) and ribonuclease A (60) at 90-100°C
`and pH 4 was found to be due to peptide bond cleavage at
`Asp-X bonds.
`It is now well established that Asp-Pro peptide bonds
`are particularly labile and are hydrolyzed under conditions
`where other Asp peptide bonds are stable (136). For exam(cid:173)
`ple, when rabbit antibody light chain was subjected to 10%
`acetic acid-pyridine (pH 2.5) in 7 M guanidinium hydrochlo-
`
`CJ
`
`CH--c-Nl+--fl'
`~
`N~peptide bond fission
`
`CJ
`
`CH2
`
`CH--c-Nl+--fl'
`II
`0
`
`NH
`2
`
`0
`II
`,......c,
`CH2
`I
`I
`&'NH/
`R---C
`j
`0
`_,......c,
`II
`I
`I
`R--C
`I
`u
`O
`~J-Q-1
`c~A-a-i
`I
`
`0
`II
`CH2-C--- Q-1
`I
`R--C-NH--cH--c-Nl+--fl'
`II
`II
`0
`0
`Aspartyl peptide
`
`/
`
`C•peptide bond fission
`
`'-- H,N-R'
`
`NH,-CH--c-Nl+--fl'
`II
`0
`Fig. 4. Mechanism of degradation of aspartyl peptides in acidic
`media.
`
`ride (GnHCl) for 24-90 hr, selective cleavage was ob(cid:173)
`served at Asp 109-Pro110 (137). Piszkiewicz et al. have sug(cid:173)
`gested that the hydrolytic reaction proceeds via intramolec(cid:173)
`ular catalysis by carboxylate anion displacement of the
`protonated nitrogen of the peptide bond and the rate en(cid:173)
`hancement occurs due to the greater basicity of the Pro ni(cid:173)
`trogen (136). Marcus has compared the lability of the Asp(cid:173)
`Pro bonds to the lability of other peptide bonds, in particular
`to those of Asp residues (138). In his study, a variety of
`dipeptides was heated at l 10°C in 0.015 M HCl. The con(cid:173)
`centration of amino acid released during the heat treatment
`was determined by amino acid analysis. The results indi(cid:173)
`cated that Asp-Pro bonds were 8- to 20-fold more labile than
`other Asp-X or X-Asp peptide bonds. Other peptide bonds
`that do not involve Asp were found to be stable to hydrolysis
`under these conditions.
`Asp-X peptide bonds also undergo a reversible isomer(cid:173)
`ization between the Asp and the iso-Asp forms via the cyclic
`imide intermediate as shown in Fig. 3 (139,140). This reac(cid:173)
`tion was first noted by Swallow and Abraham with Asp-Lys
`derived from hydrolyzates of bacitracin (139). Similar inter(cid:173)
`conversion was also shown for Val-Tyr-Pro-Asp-Gly-Ala
`(ACTH22-27), displaying a half-life of 53 days at pH 7.4 and
`37°C (26). Even storage of aqueous solutions of an Asp(cid:173)
`containing peptide can result in the formation of cyclic imide
`derivatives (141). The ring closure is particularly fast when
`an Asp residue is followed by Gly in the sequence (142).
`Peptide bonds formed by X-Ser and X-Thr are also labile,
`but require strong acidic conditions (e.g., 11.6 MHCI) (143).
`The mechanism involves N-0 acyl rearrangement (144).
`The time course of hydrolysis of amide peptide bonds
`
`Novo Nordisk A/S Ex. 2005, P. 5
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`908
`
`Manning, Patel, and Borchardt
`
`R'S+ + R"S-SR"
`
`R"S+ + R'S-SR'
`
`R'S-SR" + R"S+
`
`R"S-SR' + R'S+
`
`Fig. 6. Mechanism of disulfide exchange in acidic media.
`
`bon bearing the side chain and are subject to base catalyzed
`racemization. Racemization is generally considered to pro(cid:173)
`ceed through the removal of the a-methine hydrogen by base
`to form a carbanion (see Fig. 7) (161). Stabilization of this
`carbanion controls the rate ofrecemization. Racemization of
`amino acids in protein can generate non-metabolizable forms
`of amino acids (o-enantiomers) or create peptide bonds in(cid:173)
`accessible to proteolytic enzymes.
`The relative rates of racemization of amino acid resi(cid:173)
`dues in 37 dipeptides was studied at pH 7 .5 at 123°C by
`Smith and Desol (162). They found that the relative rates of
`racemization of amino acid residues in dipeptides is deter(cid:173)
`mined by a delicate balance of factors, including inductive
`and field effects, intramolecular base action, intramolecular
`solvation, and steric hindrance to solvation. Racemization of
`Asp is particularly interesting, because it is shown that Asp
`residues in proteins racemizes 105 -fold faster than the free
`amino acid (163), in contrast to a 2- to 4-fold increase for all
`other residues. An explanation for this exceptional behav(cid:173)
`iour of Asp is contained in the mechanism of its racemiza(cid:173)
`tion. The mechanism involves the formation of a cyclic imide
`through nucleophilic attack on the 13-carbonyl carbon by the
`a-nitrogen of the succeeding amino acid (Fig. 2). Resonance
`structures of the cyclicimide ring involve charge transfer be(cid:173)
`tween nitrogen and not only the a-carbonyl but also the
`13-carbonyl group. The latter resonance allows the peptide
`carbonyl to intensify resonance with the a-carbanion,
`formed by proton abstraction as an intermediate in the ra(cid:173)
`cemization process (164). Racemization of Asp was shown
`
`X
`I
`CHA
`_
`I
`-1-N-C-C- -
`1-> ~
`HJ
`
`Off
`
`L-amino acid residue
`
`(j
`CHA
`-
`1..,
`- -HN -C=C -t
`
`X
`I
`CHA
`I
`-1-N-C-C-
`.J ~
`
`-H' ll H'
`
`Carbanion intermediate
`
`can be monitored by gel chromatography or sodium dode(cid:173)
`cylsulfate polyacrylamide gel electrophoresis (145), and
`quantitatively assessed by gel scanning densitometry (146).
`The identities of the amino acids at the new carboxyl and
`amino termini resulting from peptide chain hydrolysis can be
`determined by hydrazinolysis/HPLC (147) and dansylation/
`TLC (148), respectively. Identification of the position of the
`new termini in the sequences of the protein can be learned
`from amino acid analysis by HPLC of the sequential digest
`of the COOH terminus by carboxypeptidases (149) and the
`NH2 terminus by the Edman degradation procedure
`(150,151). Recently, a radioass

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket